tlooto
Sign up
Medicine

Comment on "Serum IL-6 is a prognostic biomarker for advanced hepatocellular carcinoma treated with atezolizumab and bevacizumab".

Ni Xiao, Jinliang Dong, Qiujing Wang

2026.5.2Annals of Hepatology

DOI: 10.1016/j.aohep.2026.102215

Abstract

Abstract is not available.

Citation format

XIAO, Ni; DONG, Jinliang; WANG, Qiujing. Comment on "serum IL-6 is a prognostic biomarker for advanced hepatocellular carcinoma treated with atezolizumab and bevacizumab". Annals of Hepatology, 2026: 102215.